Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2024 ,inter alia, to consider and approve The Unaudited Financial Results (Standalone & Consolidation basis) of the Company for the quarter and half year ending on 30th September, 2024 in accordance with Regulation 33 of the SEBI Listing Regulation.

pdf

Eiko Lifesciences Ltd.

11 Oct 2024, 07:06PM

57.65

2.42%

Company Update

Eiko Lifesciences Ltd - 540204 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5)

pdf

Eiko Lifesciences Ltd.

08 Oct 2024

57.65

2.42%

Company Update

Eiko Lifesciences Ltd - 540204 - Updates on Open Offer

BSE India

Swaraj Shares and Securities Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement under Regulation 18(7) in terms of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to the public shareholders of Eiko Lifesciences Ltd ("Target Company")

pdf

Eiko Lifesciences Ltd.

07 Oct 2024

57.65

2.42%

Company Update

Eiko Lifesciences Ltd - 540204 - Updates on Open Offer

BSE India

Swaraj Shares and Securities Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (''IDC'') in relation to the Open Offer (''Offer'') to the public shareholders of Eiko Lifesciences Ltd ("Target Company")

pdf